Clin2
NCT07549282Possibly a fitNot yet recruiting

Nasal spray medication for heart protection during stent placement

Coronary Heart DiseaseMyocardial InjuryMyocardial InfarctionDexmedetomidine

Treatments studied

Part of Heart & circulation clinical trials.

This study tests if a calming medicine given as a nasal spray before a heart stent procedure can prevent heart muscle damage. It's for people with coronary artery disease who are scheduled for a planned stent procedure.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
140 people
Ages
18 years to 85 years
Study type
Interventional

Who can take part

  • You are between 18 and 85 years old.
  • You have coronary artery disease and are having a planned stent procedure (PCI).
  • You have mild to moderate health conditions that limit some activities but you can still do light daily tasks.
  • You do not have severe heart problems, uncontrolled high or low blood pressure, or sleep apnea.
  • Your weight gives a body mass index (BMI) of 30 or less.
  • You are not taking certain medications for blood pressure or depression within a week of surgery.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07298525Not yet recruiting· Phase 4
Safety of a sedative nasal spray before surgery with less monitoring

This trial tests a nasal spray sedative (dexmedetomidine) given before surgery to see if it's safe when there's less monitoring. It may help people who need general, spinal, or nerve block anesthesia feel calm and comfortable.

NCT07611890Recruiting· Phase 4
Comparing two medications to reduce heart stress during cardiac surgery

This trial tests whether dexmedetomidine or lignocaine better prevents dangerous heart-rate and blood-pressure changes when a breathing tube is placed during heart surgery. If you're having cardiac surgery and are at high risk for heart complications, this study may help protect your heart during the procedure.

Rawalpindi, Punjab Province
NCT06082856Recruiting
Dexmedetomidine for heart stability during outpatient surgery

This trial tests whether a drug called dexmedetomidine, given during general anesthesia, helps keep your heart rate and blood pressure stable during outpatient surgery. It may be an option if you are having a minor surgery and are not on certain heart medications.

Nîmes
NCT07165483Recruiting
Timing of dexmedetomidine for surgery stress response

This trial tests whether giving a single dose of dexmedetomidine (a medicine that helps calm the body's stress response) before surgery can reduce the stress on your heart and blood pressure when a breathing tube is placed. It may help you recover more smoothly.

Tanta, El-Gharbia
NCT06631534Recruiting· Phase 4
Testing dexmedetomidine for kids having heart defect closure

This trial tests adding a sedative medicine called dexmedetomidine to standard anesthesia for children aged 3 to 12 who are having a procedure to close a hole in their heart (atrial septal defect). The goal is to see if it helps them recover more smoothly.

Alexandria, Alexandria Governorate
NCT04289142Recruiting· Phase 4
Testing memory effects of dexmedetomidine during heart surgery

This study looks at how a sleep medicine called dexmedetomidine affects thinking and memory after heart surgery. It compares cognitive outcomes over time to see if this sedation choice changes long-term brain function.

Vancouver, British Columbia

Hear when a new Coronary Heart Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.